U.S. flag

An official website of the United States government

NM_001110556.2(FLNA):c.7756+8A>G AND not specified

Germline classification:
Benign/Likely benign (2 submissions)
Last evaluated:
Nov 6, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000153247.15

Allele description [Variation Report for NM_001110556.2(FLNA):c.7756+8A>G]

NM_001110556.2(FLNA):c.7756+8A>G

Genes:
LOC107988032:Xq28 proximal FLNA-EMD recombination region [Gene]
FLNA:filamin A [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq28
Genomic location:
Preferred name:
NM_001110556.2(FLNA):c.7756+8A>G
HGVS:
  • NC_000023.11:g.154349354T>C
  • NG_011506.2:g.30285A>G
  • NG_050800.1:g.13543T>C
  • NM_001110556.2:c.7756+8A>GMANE SELECT
  • NM_001456.4:c.7732+8A>G
  • LRG_1340t1:c.7756+8A>G
  • LRG_1340:g.30285A>G
  • NC_000023.10:g.153577722T>C
  • NM_001456.3:c.7732+8A>G
Links:
dbSNP: rs201663443
NCBI 1000 Genomes Browser:
rs201663443
Molecular consequence:
  • NM_001110556.2:c.7756+8A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001456.4:c.7732+8A>G - intron variant - [Sequence Ontology: SO:0001627]
Observations:
3

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000202721Eurofins Ntd Llc (ga)
criteria provided, single submitter

(EGL Classification Definitions 2015)
Likely benign
(Apr 9, 2014)
germlineclinical testing

Citation Link,

SCV004223369Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Benign
(Nov 6, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown3not providednot providednot providednot providedclinical testing

Details of each submission

From Eurofins Ntd Llc (ga), SCV000202721.7

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided3not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided3not providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV004223369.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: FLNA c.7756+8A>G alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00053 in 180346 control chromosomes. The observed variant frequency is approximately 1703-fold of the estimated maximal expected allele frequency for a pathogenic variant in FLNA causing Periventricular Nodular Heterotopia phenotype (3.1e-07), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.7756+8A>G in individuals affected with Periventricular Nodular Heterotopia and no experimental evidence demonstrating its impact on protein function have been reported. Five submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 7, 2024